Cutaneous manifestations of COVID-19 in a tertiary COVID-19 referral hospital in the PhilippinesCapsule Summary
Background: Reports on COVID-19 skin manifestations and associated clinical outcomes are limited. Like viral diseases, cutaneous findings may be present and can help in confirmation and prognostication among those suspected or diagnosed with COVID-19. Objective: To determine COVID-19 cutaneous manif...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Book |
| Published: |
Elsevier,
2022-06-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_a3ea973fd6c048c7b8e5540f0e3e03d2 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Cyrene C. Tan, MD |e author |
| 700 | 1 | 0 | |a Belen L. Dofitas, MD, FPDS |e author |
| 700 | 1 | 0 | |a Ma. Lorna F. Frez, MD, FPDS |e author |
| 700 | 1 | 0 | |a Celina Daia D. Yap, MD |e author |
| 700 | 1 | 0 | |a Jeanie Karen K. Uy, MD |e author |
| 700 | 1 | 0 | |a Cynthia P. Ciriaco-Tan, MD, FPDS |e author |
| 245 | 0 | 0 | |a Cutaneous manifestations of COVID-19 in a tertiary COVID-19 referral hospital in the PhilippinesCapsule Summary |
| 260 | |b Elsevier, |c 2022-06-01T00:00:00Z. | ||
| 500 | |a 2666-3287 | ||
| 500 | |a 10.1016/j.jdin.2022.01.007 | ||
| 520 | |a Background: Reports on COVID-19 skin manifestations and associated clinical outcomes are limited. Like viral diseases, cutaneous findings may be present and can help in confirmation and prognostication among those suspected or diagnosed with COVID-19. Objective: To determine COVID-19 cutaneous manifestations and their association with disease severity and course. Methods: This study was conducted in a designated COVID-19 referral hospital from January 1 to March 31, 2021. Skin manifestations recorded from January 1 to February 17 were retrospectively gathered. Reports from February 18 to March 31 were prospectively collected using a dermatologic checklist which was incorporated into all official medical records. Results: A total of 507 confirmed patients with COVID-19 were included. COVID-19 skin signs were detected in 39 patients (7.7%). Morbilliform lesions were most common. Skin signs were significantly associated with severe or critical cases (odds ratio, 3.4; 95% CI, 1.3-8.7) and mortality (relative risk, 2.9; 95% CI, 2.0-4.2). Limitations: Underestimation of prevalence of COVID-19 skin signs due to exclusion of outpatient and discharged patients and the subjective assessment in the retrospective part. Conclusion: Cutaneous signs were significantly associated with severe/critical COVID-19 as well as death among 507 hospitalized patients in a Philippine COVID-19 referral hospital. | ||
| 546 | |a EN | ||
| 690 | |a clinical outcome | ||
| 690 | |a COVID-19 | ||
| 690 | |a cutaneous manifestations | ||
| 690 | |a disease severity | ||
| 690 | |a skin | ||
| 690 | |a Dermatology | ||
| 690 | |a RL1-803 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n JAAD International, Vol 7, Iss , Pp 44-51 (2022) | |
| 787 | 0 | |n http://www.sciencedirect.com/science/article/pii/S2666328722000104 | |
| 787 | 0 | |n https://doaj.org/toc/2666-3287 | |
| 856 | 4 | 1 | |u https://doaj.org/article/a3ea973fd6c048c7b8e5540f0e3e03d2 |z Connect to this object online. |